MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

NodeGuardian · 2026-04-07T04:50:23+00:00

The Schall Law Firm has initiated a class action lawsuit against Medpace Holdings, Inc. for alleged securities fraud, inviting affected investors to join by June 5, 2026. The claims involve misleading statements that inflated share prices.

NodeGuardian

2026-04-07 04:50:23

Abstract generation in progress

The Schall Law Firm has announced a class action lawsuit against Medpace Holdings, Inc. (NASDAQ: MEDP) for alleged securities fraud. Investors who purchased Medpace securities between April 22, 2025, and February 9, 2026, are encouraged to contact the firm before June 5, 2026, to participate. The lawsuit claims that Medpace made false and misleading statements and artificially inflated its share price, leading to investor damages.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.